Icahn School of Medicine at Mount Sinai Nuclear Medicine

Topics

• Medical Imaging Techniques and Applications 62
• Radiopharmaceutical Chemistry and Applications 32
• Medical Imaging and Pathology Studies 25
• Neuroendocrine Tumor Research Advances 19
• Cancer Immunotherapy and Biomarkers 18
• Hepatocellular Carcinoma Treatment and Prognosis 16
• Prostate Cancer Treatment and Research 16
• Breast Cancer Treatment Studies 12
• Cardiac Imaging and Diagnostics 12
• Lymphoma Diagnosis and Treatment 12
• Parathyroid Disorders and Treatments 11
• Radiomics and Machine Learning in Medical Imaging 11

Most cited

1. PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial.

   Nature medicine · 2022 · 466 citations · Michael Farwell

2. Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study.

   Lancet (London, England) · 2024 · 251 citations · Randy Yeh

3. Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter Study.

   Clinical cancer research : an official journal of the American Association for Cancer Research · 2021 · 317 citations · Austin Pantel

4. Hypoxia-Directed Treatment of Human Papillomavirus-Related Oropharyngeal Carcinoma.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 93 citations · Rick Wray

5. CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of 89Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody.

   Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022 · 147 citations · Michael Farwell

6. Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells.